Human parvovirus B19: a review of clinical and epidemiological aspects in Brazil

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Cossart Y, Field A, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet 1, 72–73 (1975).
  Medline CASGoogle Scholar
• 2. Cotmore SF, Agbandje-McKenna M, Canuti M et al. ICTV virus taxonomy profile: parvoviridae. J. Gen. Virol. 100(3), 367–368 (2019).
  Medline CASGoogle Scholar
• 3. Bua G, Manaresi E, Bonvicini F, Gallinella G. Parvovirus B19 replication and expression in differentiating erythroid progenitor cells. PLoS ONE 11, e0148547 (2016).
  MedlineGoogle Scholar
• 4. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262, 114–117 (1993).
  Medline CASGoogle Scholar
• 5. Heegaard ED, Brown KE. Human parvovirus B19. Clin. Microbiol. Rev. 15(3), 485–505 (2002).
  MedlineGoogle Scholar
• 6. Qiu J, Soderlund-Venermo M, Young NS. Human parvoviruses. Clin. Microbiol. Rev. 30(1), 43–113 (2017).
  MedlineGoogle Scholar
• 7. Gallinella G. The clinical use of parvovirus B19 assays: recent advances. Expert Rev. Mol. Diagn. 18, 821–832 (2018).
  Medline CASGoogle Scholar
• 8. Bonvicini Bua G, Gallinella G. Parvovirus B19 infection in pregnancy-awareness and opportunities. Curr. Opin. Virol. 27, 8–14 (2017).
  MedlineGoogle Scholar
• 9. Cruz AS, Serpa MJ, Barth OM, do Nascimento JP. Detection of the human parvovirus B19 in a blood donor plasma in Rio de Janeiro. Mem. Inst. Oswaldo Cruz 84(2), 279–280 (1989).
  MedlineGoogle Scholar
• 10. Takimoto S, Tanaka H, Waldman EA et al. Rapid diagnosis of parvovirus infection in patients with erythema infectious. Abst. IV Cong. Bras. Virol. 109 (1988).
  Google Scholar
• 11. Miranda MF, Linhares AC, Shirley JA. Fifth disease in children living in Belém, Brazil. Rev. Inst. Med. Trop. Sao Paulo 31(5), 359–362 (1989).
  MedlineGoogle Scholar
• 12. Nascimento JP, Buckley MM, Brown KE, Cohen BJ. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev. Inst. Med. Trop. Sao Paulo 32(1), 41–45 (1990).
  Medline CASGoogle Scholar
• 13. Freitas RB, Wong D, Boswell F et al. Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil. J. Med. Virol. 32(4), 203–208 (1990).
  MedlineGoogle Scholar
• 14. Cubel RC, Alferes AC, Cohen BJ, Nascimento JP. Application to immunoglobulin M capture hemadherence assays of hemagglutination of monkey erythrocytes by native and recombinant human parvovirus B19 antigens. J. Clin. Microbiol. 32(8), 1997–1999 (1994).
  Medline CASGoogle Scholar
• 15. Cubel RC, Oliveira SA, Brown DW, Cohen BJ, Nascimento JP. Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva. J. Clin. Microbiol. 34(1), 205–207 (1996).
  Medline CASGoogle Scholar
• 16. Pereira RF, Paula WN, Cubel Rde C, Nascimento JP. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection. Mem. Inst. Oswaldo Cruz 96(4), 507–513 (2001).
  Medline CASGoogle Scholar
• 17. Cubel RC, Valadão MC, Pereira WV, Magalhães MC, Nascimento JP. Aplastic crisis due to human parvovirus B19 infection in hereditary hemolytic anaemia. Rev. Inst. Med Trop Sao Paulo 34(5), 479–482 (1992).
  Medline CASGoogle Scholar
• 18. Cohen BJ, Bates CM. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J. Virol. Methods 55(1), 11–25 (1995).
  Medline CASGoogle Scholar
• 19. Söderlund M, Brown CS, Spaan WJ, Hedman L, Hedman K. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J. Infect. Dis. 172(6), 1431–1436 (1995).
  Medline CASGoogle Scholar
• 20. Huatuco EM, Durigon EL, Lebrun FL et al. Seroprevalence of human parvovirus B19 in a suburban population in São Paulo, Brazil. Rev. Saude Publica 42(3), 443–449 (2008).
  Medline CASGoogle Scholar
• 21. Slavov SN, Kashima S, Silva-Pinto AC, Covas DT. Genotyping of Human parvovirus B19 among Brazilian patients with hemoglobinopathies. Can. J. Microbiol. 58(2), 200–205 (2012a).
  Medline CASGoogle Scholar
• 22. Slavov SN, Haddad SK, Silva-Pinto AC et al. Molecular and phylogenetic analyses of human parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors. J. Med. Virol. 84(10), 1652–1665 (2012b).
  Medline CASGoogle Scholar
• 23. Slavov SN, Kashima S, Rocha-Junior MC et al. Frequent human parvovirus B19 DNA occurrence and high seroprevalence in haemophilic patients from a non-metropolitan blood centre. Brazil. Transfus. Med. 24(2), 130–132 (2014). • Discusses frequent B19V circulation in hemophilic patients.
  Medline CASGoogle Scholar
• 24. Slavov SN, Rodrigues ES, Sauvage V et al. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern. Brazil. J. Med. Virol. 91(7), 1224–1231 (2019a).
  Medline CASGoogle Scholar
• 25. Freitas RB, Gusmão SRB, Durigon EL, Linhares AC. Survey of parvovirus B19 infection in a cohort of pregnant women in Belém, Brazil. Braz. J. Infect. Dis. 3(1), 6–14 (1999).
  MedlineGoogle Scholar
• 26. Gonçalves CV, Duarte G, Marcolin AC et al. Avaliação longitudinal da infecção por parvovírus B19 entre grávidas em Ribeirão Preto, SP, Brasil. Rev. Bras. Ginecol. Obstet. 25, 317–321 (2003).
  Google Scholar
• 27. Silva ARA, Nogueira SA, Alzeguir JCL, Costa MCFL, Nascimento JP. Anti-parvovirus B19 IgG antibody prevalence in pregnant women during antenatal follow-up and cases of non-immune hydropsis fetalis due to parvovirus B19, in the City of Rio de Janeiro. Rev. Soc. Bras. Med. Trop. 39(5), 467–472 (2006).
  MedlineGoogle Scholar
• 28. Rios WLF, Moraes CL, Melo NC et al. Prevalência da infecção pelo parvovírus B19 em mulheres com idade fértil no município de Goiânia. Rev. Patol. Trop. 45(1), 1–11 (2016).
  Google Scholar
• 29. Silva NFA, Cilião-Alves DC, Carvalho AM et al. Serological and molecular evaluation of parvovirus B19 (B19V) in blood donors from the Blood Center of Brasília, Brazil: focus on women of childbearing age. J. Bras. Patol. Med. Lab. Rio de Janeiro 54(4), 241–244 (2018).
  CASGoogle Scholar
• 30. Aguiar FS, Lopes DP, Bazin AR, Setúbal S, Cohen BJ, Nascimento JP. Human, parvovirus B19 infection in HIV-positive patients. Rev. Soc. Bras. Med. Trop. 34(3), 239–242 (2001).
  Medline CASGoogle Scholar
• 31. Azevedo KML, Setúbal S, Camacho LAB, Velarde LGC, Oliveira SA. Seroepidemiological study of human parvovirus B19 among human immunodeficiency virus-infected patients in a medium-sized city in Rio de Janeiro, Brazil. Mem. Inst. Oswaldo Cruz 104(6), 901–904 (2009).
  MedlineGoogle Scholar
• 32. Alves MT, Vilaça SS, Godoi LC et al. Parvovirus B19 (B19) and cytomegalovirus (CMV) infections and anti-erythropoietin (anti-EPO) antibodies in patients on dialysis hyporesponsive to erythropoietin therapy. Clin. Chim. Acta 431, 52–57 (2014).
  Medline CASGoogle Scholar
• 33. Lisboa CP, Sáez-Alquézar A, Stewien KE et al. Blood donors screening for parvovirus B19 using polymerase chain reaction. Abst. VIII Encontro Nacional de Virologia 134, (1996).
  Google Scholar
• 34. Setúbal S, Cárdias CA, Oliveira SA, Nascimento JP. Viremic blood donor found by a rapid screening method in a season of high human parvovirus B19 activity in Niterói, Rio de Janeiro, Brazil. Mem. Inst. Oswaldo Cruz 99(1), 95–99 (2004).
  MedlineGoogle Scholar
• 35. Slavov SN, Otaguiri KK, Covas DT, Kashima S. Prevalence and viral load of human parvovirus B19 (B19V) among blood donors in south-east Brazil. Indian J. Hematol. Blood Transfus. 32(Suppl. 1), 323–325 (2016).
  MedlineGoogle Scholar
• 36. Slavov SN, Gonçalves de Noronha LA, Gonzaga FAC, Pimentel BMS, Kashima S, Haddad R. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from central-west Brazil. J. Med. Microbiol. 68(4), 622–626 (2019b).
  Medline CASGoogle Scholar
• 37. Servant-Delmas A, Lefrère JJ, Morinet F, Pillet S. Advances in human B19 erythrovirus biology. J. Virol. 84(19), 9658–9665 (2010).
  Medline CASGoogle Scholar
• 38. Sanabani S, Neto WK, Pereira J, Sabino EC. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J. Clin. Microbiol. 44(2), 604–606 (2006).
  Medline CASGoogle Scholar
• 39. Alves AD, Melgaço JG, Garcia RCNC et al. Persistence of parvovirus B19 in liver from transplanted patients with acute liver failure. Future Microbiol. 15, 307–317 (2020). •• Studies the role of the B19V in liver injury.
  CASGoogle Scholar
• 40. Freitas RB, Melo FL, Oliveira DS et al. Molecular characterization of human erythrovirus B19 strains obtained from patients with several clinical presentations in the Amazon region of Brazil. J. Clin. Virol. 43(1), 60–65 (2008). • Reports the circulation of genotypes 1 and 3b in patients with distinct clinical conditions in the Amazon region.
  Medline CASGoogle Scholar
• 41. Figueiredo RMP, Souza VC, Nascimento VAD, Naveca FG. Human parvovirus B19 genotype 1 in suspected dengue patients of Tefé, Amazonas State, Brazil. Rev. Soc. Bras. Med. Trop. 52, e20190304 (2019).
  MedlineGoogle Scholar
• 42. Keller LW, Barbosa ML, Melo FL et al. Phylogenetic analysis of a near-full-length sequence of an erythrovirus genotype 3 strain isolated in Brazil. Arch. Virol. 154(10), 1685–1687 (2009).
  Medline CASGoogle Scholar
• 43. Garcia SO, Kleine Neto W, Costa AC et al. Parvovirus among patients with cytopenia of unknown origin in Brazil: a case-control study. J. Clin. Microbiol. 49(4), 1578–1580 (2011).
  MedlineGoogle Scholar
• 44. Costa AC, Bendit I, Oliveira ACS, Kallas EG, Sabino EC, Sanabani SS. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities. Clin. Microbiol. Infect. 19(1), E31–E43 (2013). •• Demonstrates monoinfection and coinfection (1a and 3b) in patients with leukemia and intergenotypic recombination (1a/3b) in a single patient.
  MedlineGoogle Scholar
• 45. Oliveira MI, Afonso AMS, Curti SP et al. Genotype 1 of human parvovirus B19 in clinical cases. Rev. Assoc. Med. Bras. 63(3), 224–228 (2017).
  MedlineGoogle Scholar
• 46. Slavov SN, Kashima S, Silva-Pinto AC, Amarilla AA, Aquino VH, Covas DT. Molecular and clinical evaluation of the acute human parvovirus B19 infection: comparison of two cases in children with sickle cell disease and discussion of the literature. Braz. J. Infect. Dis. 17(1), 97–101 (2013). • Reports one case of Transient aplastic crisis requiring emergency transfusions, while the other had asymptomatic infection, diagnosed occasionally.
  MedlineGoogle Scholar
• 47. Di Paola N, Mesquita FS, Oliveira DBL et al. An outbreak of human parvovirus B19 hidden by dengue fever. Clin. Infect. Dis. 68(5), 810–817 (2019).
  MedlineGoogle Scholar
• 48. Mendonça MC, Ferreira AM, Santos MG, Barros JJF, von Hubinger MG, Couceiro JNSS. Heteroduplex mobility assay and single-stranded conformation polymorphism analysis as methodologies for detecting variants of human erythroviruses. J. Virol. Methods 148(1–2), 40–47 (2008).
  MedlineGoogle Scholar
• 49. Mendonça MC, Ferreira AM, Santos MG et al. Genotyping of human parvovirus B19 in clinical samples from Brazil and Paraguay using heteroduplex mobility assay, single-stranded conformation polymorphism and nucleotide sequencing. Mem. Inst. Oswaldo Cruz 106(4), 502–504 (2011).
  MedlineGoogle Scholar
• 50. Cubel Garcia RC, Pereira RF, Azevedo KM et al. Molecular diversity of human parvovirus B19 during two outbreaks of erythema infectiosum in Brazil. Braz. J. Infect. Dis. 21(1), 102–106 (2017).
  MedlineGoogle Scholar
• 51. Pereira RF, Garcia RCNC, Azevedo KML, Setúbal S, Siqueira MAMT, Oliveira SA. Clinical features and laboratory findings of human parvovirus B19 in human immunodeficiency virus-infected patients. Mem. Inst. Oswaldo Cruz 109(2), 168–173 (2014).
  MedlineGoogle Scholar
• 52. Leon LAA, Alves ADR, Garcia RCNC, Melgaço JG, Paula FS, Pinto MA. Parvovirus B19 infection in a fatal case of acute liver failure. Pediatr. Infect. Dis. J. 36(12), e355–e358 (2017).
  MedlineGoogle Scholar
• 53. Gama BE, Emmel VE, Oliveira-Silva M et al. Parvovirus B19 in the context of hematopoietic stem cell transplantation: evaluating cell donors and recipients. Transplant. Direct 3(11), e217 (2017).
  MedlineGoogle Scholar
• 54. Furtado MSBS, Viana MB, Hickson Rrios JS et al. Prevalence and incidence of erythrovirus B19 infection in children with sickle cell disease: the impact of viral infection in acute clinical events. J. Med. Virol. 88(4), 588–595 (2016).
  Medline CASGoogle Scholar
• 55. Furtado MSBS, Martins ML, Figueiredo RM, Viana MB. Transient red cell aplasia in two brothers with sickle cell anemia and erythrovirus B19 infection. Rev. Bras. Hematol. Hemoter. 38(3), 271–273 (2016b).
  MedlineGoogle Scholar
• 56. Freitas RB, Durigon EL, Oliveira DS et al. The “pressure pan” evolution of human erythrovirus B19 in the Amazon, Brazil. Virology 369(2), 281–287 (2007).
  MedlineGoogle Scholar
• 57. Conteville LC, Zanella L, Marín MA et al. Parvovirus B19 1A complete genome from a fatal case in Brazil. Mem. Inst. Oswaldo Cruz 110(6), 820–821 (2015).
  Medline CASGoogle Scholar
• 58. Molenaar-de Backer MW, Lukashov VV, van Binnendijk RS et al. Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions. PLoS ONE 7(8), e43206 (2012).
  MedlineGoogle Scholar
• 59. Freitas RB, Linhares AC, Miranda MFR, Gabbay YB. Novo agente de doença exantemática na Amazônia: o parvovírus “819”. Bol. Epidemiol. Rio de Janeiro 20(4), 1–4 (1988).
  Google Scholar
• 60. Freitas RB, Miranda MF, Shirley J, Tudor R, Desselberger U, Linhares AC. Parvovirus B19 antibodies in sera of patients with unexplained exanthemata from Belém, Pará, Brazil. Mem. Inst. Oswaldo Cruz 88(3), 497–499 (1993).
  MedlineGoogle Scholar
• 61. Pacheco FC, França GVA, Elidio GA, Domingues CMAS, Oliveira C, Guilhem DB. Trends and spatial distribution of MMR vaccine coverage in Brazil during 2007–2017. Vaccine 37(20), 2651–2655 (2019).
  MedlineGoogle Scholar
• 62. Salles TS, Sá-Guimarães TE, Alvarenga ESL et al. History, epidemiology and diagnostics of dengue in the American and Brazilian contexts: a review. Parasit. Vectors 11(1), 264 (2018).
  MedlineGoogle Scholar
• 63. Oliveira SA, Brandão AB, Fernandes DG et al. Human parvovirus B19 infection: clinical and epidemiological study of 24 cases. Rev. Inst. Med. Trop. Sao Paulo 38(5), 323–327 (1996).
  Medline CASGoogle Scholar
• 64. Cubel RC, Siqueira MM, Santos EO, Pires MF, Cruz CMF, Nascimento JP. Human parvovirus B19 infections among exanthematic diseases notified as measles. Rev. Soc. Bras. Med. Trop. 30(1), 15–20 (1997).
  Medline CASGoogle Scholar
• 65. Freitas RB, Monteiro TA, Linhares AC. Outbreaks of human-herpes virus 6 (HHV-6) infection in day-care centers in Belém, Pará, Brazil. Rev. Inst. Med. Trop. Sao Paulo 42(6), 305–311 (2000).
  Medline CASGoogle Scholar
• 66. Oliveira SA, Siqueira MM, Camacho LA et al. The aetiology of maculopapular rash diseases in Niterói, State of Rio de Janeiro, Brazil: implications for measles surveillance. Epidemiol. Infect. 127(3), 509–516 (2001).
  Medline CASGoogle Scholar
• 67. Oliveira MI, Curti SP, Figueiredo CA et al. Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil. Rev. Saude Publica 36(2), 155–159 (2002).
  MedlineGoogle Scholar
• 68. Oliveira SA, Camacho LA, Pereira ACM, Faillace TF, Setúbal S, Nascimento JP. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil). Mem. Inst. Oswaldo Cruz 97(7), 965–970 (2002). •• Provides clinical and demographic descriptive data of B19V cases in a 6-year study.
  MedlineGoogle Scholar
• 69. Wermelinger MC, Oelemann WM, Mendonça MCL, Naveca FG, von Hubinger MG. Detection of human parvovirus B19 infection: a study of 212 suspected cases in the state of Rio de Janeiro, Brazil. J. Clin. Virol. 25(2), 223–230 (2002).
  MedlineGoogle Scholar
• 70. Figueiredo RM, Thatcher BD, Lima ML, Almeida TC, Alecrim WD, Guerra MV. Exanthematous diseases and the first epidemic of dengue to occur in Manaus, Amazonas State, Brazil, during 1998–1999. Rev. Soc. Bras. Med. Trop. 37(6), 476–479 (2004).
  MedlineGoogle Scholar
• 71. Figueiredo RM, Lima ML, Almeida TM, Bastos MS. Occurrence of parvovirus B19 in Manaus, AM. Rev. Soc. Bras. Med. Trop. 38(5), 396–398 (2005).
  MedlineGoogle Scholar
• 72. Mendonça MC, Ribeiro SB, Couceiro JN, von Hubinger MG. Parvovirus B19 infections in state of Rio de Janeiro, Brazil: 526 sera analyzed by IgM-enzyme-linked immunosorbent assay and polymerase chain reaction. Mem. Inst. Oswaldo Cruz 100(8), 847–852 (2005).
  Medline CASGoogle Scholar
• 73. Oliveira MJC, Cordeiro MT, Costa FM et al. Frequency of measles, rubella, dengue and erythema infectiosum among suspected cases of measles and rubella in the State of Pernambuco between 2001 and 2004. Rev. Soc. Bras. Med. Trop. 41(4), 338–344 (2008).
  MedlineGoogle Scholar
• 74. Ciccone FH, Carvalhanas TRM, Afonso MAS, Flannery B, Waldman EA. Investigation of measles IgM-seropositive cases of febrile rash illnesses in the absence of documented measles virus transmission, State of São Paulo, Brazil, 2000–2004. Rev. Soc. Bras. Med. Trop. 43(3), 234–239 (2010).
  MedlineGoogle Scholar
• 75. Figueiredo RMP, Souza VC, Nascimento VAD, Naveca FG. Human parvovirus B19 genotype 1 in suspected dengue patients of Tefé, Amazonas State, Brazil. Rev. Soc. Bras. Med. Trop. 52, e20190304 (2019).
  MedlineGoogle Scholar
• 76. Fahsbender E, Charlys da-Costa A, Gill DE et al. Plasma virome of 781 Brazilians with unexplained symptoms of arbovirus infection include a novel parvovirus and densovirus. PLoS ONE 15(3), e0229993 (2020).
  Medline CASGoogle Scholar
• 77. Freitas RB, Monteiro TA, Silva Filho MG, Linhares AC. Association between human parvovirus B19 and arthropathy in Belém, Pará, North Brazil. Rev. Inst. Med. Trop. Sao Paulo 44(1), 17–22 (2002).
  MedlineGoogle Scholar
• 78. Oliveira SA, Bastos Camacho LA et al. Acute arthropathy in patients with rash diseases: a comparative study. Clin. Rheumatol. 28(9), 1067–1071 (2009).
  MedlineGoogle Scholar
• 79. Linhares AC, Miranda MFR, Freitas RB. Parvovírus B19, eritema infeccioso e outras manifestações clínicas. An. Bras. Dermatol. 66(6), 281–287 (1991).
  Google Scholar
• 80. Rosenfeld LB, Bacal NS, Cuder MAM et al. Prevalence of hemoglobinopathies in the Brazilian adult population: national health survey 2014–2015. Rev. Bras. Epidemiol. 22(Suppl. 2), E190007 (2019).
  MedlineGoogle Scholar
• 81. Borsato ML, Bruniera P, Cusato MP, Spewien KE, Durigon EL, Toporovski J. Aplastic crisis in sickle cell anemia induced by parvovírus B19. J. Pediatr. (Rio J.) 76(6), 458–460 (2000).
  Medline CASGoogle Scholar
• 82. Valera ET, Cipolotti R, Bernardes JE et al. Pancitopenia transitória induzida por parvovírus B19 [Transient pancytopenia induced by parvovirus B19 in a child with hereditary spherocytosis]. J. Pediatr. (Rio J.) 76(4), 323–326 (2000).
  Medline CASGoogle Scholar
• 83. Sant'Anna AL, Garcia RCNC, Marzoche M et al. Study of chronic hemolytic anaemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the development aplastic crises. Rev. Inst. Med. Trop. Sao Paulo 44(4), 187–190 (2002).
  MedlineGoogle Scholar
• 84. Setúbal S, Gabriel AH, Nascimento JP, Oliveira SA. Aplastic crisis caused by parvovirus B19 in an adult patient with sickle-cell disease. Rev. Soc. Bras. Med. Trop. 33(5), 477–481 (2000).
  Medline CASGoogle Scholar
• 85. Damasceno JA, Praxedes H, Praxedes MK et al. Parvovirose e anemia acentuada em paciente imunocompetente. J. Bras. Patol. Med. Lab 48(2), 117–120 (2012).
  Google Scholar
• 86. de Jong EP, Walther FJ, Kroes AC, Oepkes D. Parvovirus B19 infection in pregnancy: new insights and management. Prenat. Diagn. 31(5), 419–425 (2011).
  Medline CASGoogle Scholar
• 87. Bascietto F, Liberati M, Murgano D et al. Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 52(5), 569–576 (2018).
  Medline CASGoogle Scholar
• 88. Cubel RC, Garcia AG, Pegado CS et al. Human parvovirus B19 infection and hydrops fetalis in Rio de Janeiro, Brazil. Mem. Inst. Oswaldo Cruz 91(2), 147–151 (1996).
  Medline CASGoogle Scholar
• 89. Garcia AGP, Pegado CS, Ramos HIB, Souza Marques RL, Cubel RCN, Nascimento JP. Non-immunologic hydrops fetalis: study of 86 autopsies. Trop. Doct. 26(2), 78–79 (1996).
  Medline CASGoogle Scholar
• 90. Garcia AGP, Pegado CS, Cubel RCN, Fonseca MEF, Sloboda I, Nascimento JP. Feto-placentary pathology in human parvovirus B19 infection. Rev. Inst. Med. Trop. Sao Paulo 40(3), 145–150 (1998).
  Medline CASGoogle Scholar
• 91. Silva ARA, Alzeguir JCL, Costa MCLF et al. Hidropisia fetal. Análise de 80 casos. Rev. Bras. Ginecol. Obstet. 27(3), 143–147 (2005).
  Google Scholar
• 92. Quemelo PR, Lima DM, Fonseca BA, Peres LC. Detection of parvovirus B19 infection in formalin-fixed and paraffin-embedded placenta and fetal tissues. Rev. Inst. Med. Trop. Sao Paulo 49(2), 103–107 (2007).
  MedlineGoogle Scholar
• 93. Figueiredo CA, Oliveira MA, Afonso AMS et al. Detection of human parvovirus B19 in cases of hydrops fetalis in São Paulo, Brazil. J. Bras. Patol. Med. Lab. 44(6), 423–427 (2008).
  Google Scholar
• 94. Fritsch A, Müller ALL, Sanseverino MTV et al. Hidropisia fetal não imune: experiência de duas décadas num hospital universitário. Rev. Bras. Ginecol. Obstet. 34(7), 310–315 (2012).
  MedlineGoogle Scholar
• 95. Agra IKR, Amorim Filho AG, Lin LH, Biancolin SE, Francisco RPV, Brizot ML. Parameters associated with adverse fetal outcomes in parvovirus B19 congenital infection. Parâmetros associados a desfechos fetais adversos na infecção congênita pelo parvovírus B19. Rev. Bras. Ginecol. Obstet. 39(11), 596–601 (2017). • Investigates the clinical and sonographic parameters in fetuses with B19V congenital infection.
  MedlineGoogle Scholar
• 96. Oliveira GM, Pascoal-Xavier MA, Moreira DR et al. Detection of cytomegalovirus, herpes virus simplex, and parvovirus B19 in spontaneous abortion placentas. J. Matern. Fetal Neonatal Med. 32(5), 768–775 (2019).
  MedlineGoogle Scholar
• 97. Lowe R, Barcellos C, Brasil P et al. The Zika virus epidemic in brazil: from discovery to future implications. Int. J. Environ. Res. Public Health 15, 96 (2018).
  Google Scholar
• 98. Yamamoto L, Filho AGA, Queiroz JA et al. Performance of a multiplex nested polymerase chain reaction in detecting 7 pathogens containing DNA in their genomes associated with congenital infections. Arch. Pathol. Lab. Med. 144(1), 99–106 (2020).
  Medline CASGoogle Scholar
• 99. Setúbal S, Jorge-Pereira MC, Sant'Anna ALM, Oliveira SA, Bazin AR, Nascimento JP. Clinical presentation of parvovirus B19 infection in HIV-infected patients with and without AIDS. Rev. Soc. Bras. Med. Trop. 36(2), 299–302 (2003).
  MedlineGoogle Scholar
• 100. Azevedo KML, Setúbal S, Camacho LAB et al. Parvovirus B19 seroconversion in a cohort of human immunodeficiency virus-infected patients. Mem. Inst. Oswaldo Cruz 107(3), 356–361 (2012). • Estimates the frequency of B19 seroconversion and the occurrence of B19V-related anaemia in a cohort of HIV-infected patients.
  MedlineGoogle Scholar
• 101. Mrzljak A, Tabain I, Premac H et al. The role of emerging and neglected viruses in the etiology of hepatitis. Curr. Infect. Dis. Rep. 21(12), 51 (2019).
  MedlineGoogle Scholar
• 102. Squires JE, McKiernan P, Squires RH. Acute liver failure: an update. Clin Liver Dis. 22(4), 773–805 (2018).
  MedlineGoogle Scholar
• 103. Alves ADR, Cubel Garcia RCN, Cruz OG, Pinto MA, Amado Leon LA. Quantitative real-time PCR for differential diagnostics of parvovirus B19 infection in acute liver failure patients. Expert Rev. Mol. Diagn. 19(3), 259–266 (2019).
  Medline CASGoogle Scholar
• 104. Pinho JR, Alves VA, Vieira AF et al. Detection of human parvovirus B19 in a patient with hepatitis. Braz. J. Med. Biol. Res. 34(9), 1131–1138 (2001).
  Medline CASGoogle Scholar
• 105. Langnas AN, Markin RS, Cattral MS, Naides SJ. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22(6), 1661–1665 (1995).
  Medline CASGoogle Scholar
• 106. Díaz F, Collazos J. Hepatic dysfunction due to parvovirus B19 infection. J. Infect. Chemother. 6(1), 63–64 (2000).
  Medline CASGoogle Scholar
• 107. Ozçay F, Bikmaz YE, Canan O, Ozbek N. Hepatitis A and parvovirus B19 infections in an infant with fulminant hepatic failure. Turk. J. Gastroenterol. 17(2), 148–150 (2006).
  MedlineGoogle Scholar
• 108. Kishore J, Sen M. Parvovirus B19-induced thrombocytopenia and anemia in a child with fatal fulminant hepatic failure coinfected with hepatitis A and E viruses. J. Trop. Pediatr. 55(5), 335–337 (2009).
  MedlineGoogle Scholar
• 109. Dwivedi M, Manocha H, Tiwari S, Tripathi G, Dhole TN. Coinfection of parvovirus B19 with other hepatitis viruses leading to fulminant hepatitis of unfavorable outcome in children. Pediatr. Infect. Dis. J. 28(7), 649–650 (2009).
  MedlineGoogle Scholar
• 110. Wong S, Young NS, Brown KE. Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J. Infect. Dis. 187(10), 1581–1586 (2003).
  MedlineGoogle Scholar
• 111. Opaleye OO, Fagbami AH, Lalremruata A, Kun JF. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria. J. Med. Virol. 83(4), 710–716 (2011).
  Medline CASGoogle Scholar
• 112. Leon LA, Marchevsky RS, Gaspar AM et al. Cynomolgus monkeys (Macaca fascicularis) experimentally infected with B19V and hepatitis A virus: no evidence of the co-infection as a cause of acute liver failure. Mem. Inst. Oswaldo Cruz 111(4), 258–266 (2016).
  Medline CASGoogle Scholar
• 113. Passoni LF, Ribeiro SR, Giordani ML et al. Papular-purpuric “gloves and socks” syndrome due to parvovirus B19: report of a case with unusual features. Rev. Inst Med. Trop. Sao Paulo 43(3), 167–170 (2001).
  Medline CASGoogle Scholar
• 114. Toyoshima MT, Keller LW, Barbosa ML, Durigon EL. Papular-purpuric “gloves and socks” syndrome caused by parvovirus B19 infection in Brazil: a case report. Braz. J. Infect. Dis. 10(1), 62–64 (2006).
  MedlineGoogle Scholar
• 115. Pereira ACM, Barros RAQ, Nascimento JP, Oliveira SA. Two family members with a syndrome of headache and rash caused by human parvovirus B19. Braz. J. Infect. Dis. 5(1), 37–39 (2001).
  Medline CASGoogle Scholar
• 116. Grillo E, Silva RJM. Childhood chorea-encephalopathy and unremarkable MRI: an association suggesting parvovirus B19 infection. Dev. Med. Child Neurol. 51(9), 759–761 (2009).
  MedlineGoogle Scholar
• 117. Oliveira MI, Afonso AMS, Figueiredo CA, Curti SP, Klautau GB, Sallum MAM. Molecular characterization of human parvovirus B19 associated with neuromyelitis. Rev. Pan-Amaz. Saude 2(2), 71–74 (2011).
  CASGoogle Scholar
• 118. Freitas GRR, Praxedes MRG, Malheiros D, Testagrossa L, Dias CB, Woronik V. Glomeruloesclerose segmentar e focal (GESF) colapsante associada ao parvovírus B19: relato de caso. J. Bras. Nefrol. 37(1), 121–126 (2015).
  MedlineGoogle Scholar
• 119. Cugler T, Carvalho LM, Facincani I et al. Severe glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking systemic lupus erythematosus. Scand. J. Rheumatol. 41(1), 79–81 (2012).
  Medline CASGoogle Scholar
• 120. Costa PS, Ribeiro GM, Vale TC, Casali TG, Leite FJ. Adult Reye-like syndrome associated with serologic evidence of acute parvovirus B19 infection. Braz. J. Infect. Dis. 15(5), 482–483 (2011).
  MedlineGoogle Scholar